ArticleScientific reports2019

Intranasal and epicutaneous administration of Toll-like receptor 7 (TLR7) agonists provides protection against influenza A virus-induced morbidity in mice.

Eunice E To et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.